China’s pharmaceutical sector, a minor player just years ago, has revved up into a global juggernaut faster than a Fuxing high speed train.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US patients.
At the heart of the biotech deal is a relatively new drug technology called PD-1/VEGF bispecific antibodies.